Posts with tag ERA

This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation. To view our first article and the whole series, please click here. As part of the revision of the EU pharmaceutical legislative framework, a new directive on medicinal products for human use is proposed, which will repeal Directive 2001/83/EC.[1] One of the objectives of this proposed directive is to reduce the environmental impact of medicinal products. This proposal strengthens...